Dr Scott A Olex, DO | |
255 W Lancaster Ave, Paoli, PA 19301-1763 | |
(484) 565-1510 | |
(484) 565-1513 |
Full Name | Dr Scott A Olex |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 20 Years |
Location | 255 W Lancaster Ave, Paoli, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033311493 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OS014083 (Pennsylvania) | Secondary |
208M00000X | Hospitalist | OS014083 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Riddle Memorial Hospital | Media, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Main Line Healthcare | 1951215201 | 894 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Max Kamin-Cross, a self-proclaimed political junky and youth activist, writes that by improving access to contraceptives, "we could lift millions of people of all races and both genders out of poverty throughout the world," "we could significantly decrease the number of premature deaths, as well as the number of lives claimed by deadly infections like HIV," and "the quality of life for millions more people would be drastically improved."
A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center - Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.
Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.
Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer.
› Verified 2 days ago
Entity Name | Main Line Healthcare |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Max Kamin-Cross, a self-proclaimed political junky and youth activist, writes that by improving access to contraceptives, "we could lift millions of people of all races and both genders out of poverty throughout the world," "we could significantly decrease the number of premature deaths, as well as the number of lives claimed by deadly infections like HIV," and "the quality of life for millions more people would be drastically improved."
A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center - Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.
Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.
Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Scott A Olex, DO 255 W Lancaster Ave, Paoli, PA 19301-1763 Ph: (484) 565-1510 | Dr Scott A Olex, DO 255 W Lancaster Ave, Paoli, PA 19301-1763 Ph: (484) 565-1510 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Max Kamin-Cross, a self-proclaimed political junky and youth activist, writes that by improving access to contraceptives, "we could lift millions of people of all races and both genders out of poverty throughout the world," "we could significantly decrease the number of premature deaths, as well as the number of lives claimed by deadly infections like HIV," and "the quality of life for millions more people would be drastically improved."
A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center - Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.
Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.
Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer.
› Verified 2 days ago
Arun Minupuri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 484-565-1510 | |
Dr. Hammad Raza, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 484-565-1510 Fax: 484-565-1513 |